Financials

	2024	2025
Net sales	492K 441K 408K 370K 691K 46.86M 699K 4.88M 1.94M 24.52M 1.85M 1.81M 77.84M	89K 79.85K 73.83K 66.86K 125K 8.48M 126K 883K 352K 4.44M 334K 327K 14.08M
Net income	-1.04M -933K -863K -781K -1.46M -99.05M -1.48M -10.31M -4.11M -51.83M -3.9M -3.82M -165M	-3.98M -3.57M -3.3M -2.99M -5.58M -379M -5.65M -39.43M -15.71M -198M -14.92M -14.61M -629M
Net Debt	6.22M 5.58M 5.16M 4.67M 8.73M 592M 8.83M 61.66M 24.56M 310M 23.33M 22.84M 984M	911K 817K 756K 684K 1.28M 86.76M 1.29M 9.04M 3.6M 45.4M 3.42M 3.35M 144M

Projected Income Statement - Annual - VVT Med Inc.

* Estimated data More financial data

Company Profile

DXI Capital Corp. is a Canada-based company. The Company has no active operations. It does not generate revenue from its operations. The Companyâ€™s wholly owned subsidiary is 0855524 B.C. Ltd.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
23/10/26	CAD 0.1950	0.00%	509
22/10/26	CAD 0.1950	0.00%	500

Delayed Quote Toronto S.E.

More quotes

Market Closed - Toronto S.E. 06:54:40 24/10/26 am AEDT			5-day change	1st Jan Change
0.1950 ^CAD	0.00%		0.00%	-35.00%

22/10	VVT Med Inc. Enters Panama Market Through Trial Distribution Agreement With Ebtec For ScleroSafe	CI
02/10	VVT Med Enters Exclusive Canadian Commercial Partnership With CHS	MT

Market Cap	10.68M 9.58M 8.86M 8.02M 14.99M 1.02B 15.17M 106M 42.19M 532M 40.08M 39.24M 1.69B	P/E 2024 *	-	P/E 2025	-2.71x
Enterprise Value	11.59M 10.4M 9.62M 8.71M 16.27M 1.1B 16.47M 115M 45.79M 578M 43.5M 42.58M 1.83B	EV / Sales 2024 *	-	EV / Sales 2025	175x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

22/10	VVT Med Inc. Enters Panama Market Through Trial Distribution Agreement With Ebtec For ScleroSafe	CI
02/10	VVT Med Enters Exclusive Canadian Commercial Partnership With CHS	MT
02/10	VVT Med Inc. and CHS Ltd. Establish Exclusive Canadian Commercial Partnership with CHS for ScleroSafe	CI
12/09	VVT Med Raises Total of $1.9 Million After Closing Second Tranche of Private Placement	MT
02/09	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI
01/09	VVT Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
01/07	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
01/07	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/06	VVT Med Inc. Auditor Raises 'Going Concern' Doubt	CI
26/06	VVT Med Signs Exclusive Distribution Deal in Greece Worth About C$1.14 Million	MT
26/06	VVT Med Inc. Enters Exclusive Distribution Agreement With General Chemical Products S.A. For ScleroSafe Platform In Greece	CI
12/06	VVT Med Enters Dominican Republic Market	MT
11/06	VVT Med Inc. Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	CI

02/10	VVT Med Establishes Exclusive Canadian Commercial Partnership with CHS for ScleroSafe®	AQ
11/09	VVT Med Closes Second Tranche of Private Placement of Units; Over $1.8M in Total Proceeds Raised	AQ
02/09	VVT Med Advances Portugal Market Entry as Dermworks Begins ScleroSafe® Market Evaluation and Announces Corporate Updates	AQ
22/08	VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure	AQ
26/06	VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece	AQ

VVT Med Inc. Stock

Stocks

VVTM

CA91841T1084

Medical Equipment, Supplies & Distribution

Valuation: VVT Med Inc.

Chart: VVT Med Inc.

Latest news: VVT Med Inc.

Press Releases: VVT Med Inc.

News in other languages: VVT Med Inc.

Quotes and Performance

Price Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

27/11	VVT Medical Inc. (VVTM) ouvre les marchés
24/11/23	Sopra Steria Group: Willy il Coyote cerca di tenere il passo con Bip Bip
23/11/23	Sopra Steria Group: Coyote intenta seguir el ritmo de Bip Bip
23/11/23	Sopra Steria Group : le Coyote tente de suivre Bip Bip

Current month	-2.50%
1 month	-2.50%
3 months	-30.36%
6 months	-22.00%
Current year	-35.00%

1 week	0.2	0.2
1 month	0.18	0.2
Current year	0.15	0.45
1 year	0.15	0.45
3 years	0.15	0.56
5 years	0.15	0.56
10 years	0.15	0.56

Date	Insider	Type	Main position	% Market Cap.
28/4/26	Erez Tetro	Other	Chief Executive Officer	0%
27/4/26	Yair Aloni	Other	Chairman	0%
27/4/26	Yair Aloni	Other	Chairman	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VVT MED INC.	0.00%	0.00%	-44.29%	-	10.64M
ABBOTT LABORATORIES	-0.45%	+2.12%	-18.93%	+10.37%	178B
STRYKER CORPORATION	+0.86%	+2.15%	-19.13%	+15.77%	116B
MEDTRONIC PLC	+0.88%	+1.88%	+1.66%	+35.46%	115B
ESSILORLUXOTTICA	-2.26%	+18.07%	-43.85%	+5.76%	93.1B
CENCORA, INC.	-0.31%	-4.72%	-3.36%	+74.94%	62.09B
HOYA CORPORATION	+0.17%	+1.64%	+8.50%	+82.24%	55.87B
BECTON, DICKINSON AND COMPANY	+0.07%	+0.42%	+5.94%	-22.27%	53.12B
IDEXX LABORATORIES, INC.	+0.30%	+1.70%	-11.26%	+42.01%	44.22B
ALCON INC.	+0.10%	+3.08%	-3.06%	-8.74%	33.59B
Average	+0.09%	+2.05%	-12.78%	+26.17%	75.1B
Weighted average by Cap.	+0.21%	+2.37%	-12.65%	+23.85%